152 related articles for article (PubMed ID: 21513537)
21. Glycogen-rich mesothelioma.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 1999; 23(6):401-6. PubMed ID: 10626691
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report.
Costanzo L; Scarlata S; Perrone G; Rossi L; Papa A; Di Matteo FM; Tonini G; Onetti Muda A; Antonelli-Incalzi R; Tomao S
Clin Respir J; 2014 Jan; 8(1):124-9. PubMed ID: 24118858
[TBL] [Abstract][Full Text] [Related]
23. Malignant pleural mesothelioma with osseous metastases and pathologic fracture of femoral neck.
Lester T; Xu H
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):507-9. PubMed ID: 18580495
[TBL] [Abstract][Full Text] [Related]
24. Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
Trupiano JK; Geisinger KR; Willingham MC; Manders P; Zbieranski N; Case D; Levine EA
Mod Pathol; 2004 Apr; 17(4):476-81. PubMed ID: 14976533
[TBL] [Abstract][Full Text] [Related]
25. Pleural mesothelioma: diagnostic problems and evaluation of prognostic factors.
Ismail HM; Nouh MA; Abulkheir IL; Abd El-Rahman Ael-R; Tawfik HN
J Egypt Natl Canc Inst; 2006 Dec; 18(4):303-10. PubMed ID: 18301454
[TBL] [Abstract][Full Text] [Related]
26. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells.
Tsukiji H; Takeshima Y; Amatya VJ; Kushitani K; Inai K
Histopathology; 2010 Jun; 56(7):969-74. PubMed ID: 20636799
[No Abstract] [Full Text] [Related]
27. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):373-83. PubMed ID: 16400322
[TBL] [Abstract][Full Text] [Related]
28. Malignant pleural mesothelioma forming a huge mediastinal mass and causing atrial fibrillation.
Kuwabara H; Tsuji H; Inada Y; Shibayama Y
Indian J Pathol Microbiol; 2012; 55(4):513-5. PubMed ID: 23455791
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary mesothelioma in bronchioalveolar lavage: a case report.
Akinfolarin J; Black A; Al-Abbadi M
Diagn Cytopathol; 2008 Mar; 36(3):190-2. PubMed ID: 18232009
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma.
Leers MP; Aarts MM; Theunissen PH
Histopathology; 1998 Mar; 32(3):209-16. PubMed ID: 9568505
[TBL] [Abstract][Full Text] [Related]
31. Malignant mesothelioma presenting in the pleura and peritoneum.
Wouters EF; Havenith MG; Vermeulen A; Greve LH
Neth J Med; 1984; 27(6):213-7. PubMed ID: 6462309
[No Abstract] [Full Text] [Related]
32. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure.
Gloeckner-Hofmann K; Zhu XZ; Bartels H; Feller AC; Merz H
Respiration; 2000; 67(4):456-8. PubMed ID: 10940805
[TBL] [Abstract][Full Text] [Related]
33. 71-year-old man with multiple metastases to the brain. Malignant mesothelioma with cerebellar metastasis.
Hortobágyi T; Thomas NW; King A
Neuropathology; 2008 Feb; 28(1):103-5. PubMed ID: 18021192
[No Abstract] [Full Text] [Related]
34. Spindle cell tumors of the pleura: differential diagnosis.
Rdzanek M; Fresco R; Pass HI; Carbone M
Semin Diagn Pathol; 2006 Feb; 23(1):44-55. PubMed ID: 17044195
[TBL] [Abstract][Full Text] [Related]
35. Use of immunohistochemical marker calretinin in the diagnosis of a diffuse malignant metastatic mesothelioma in an equine.
Stoica G; Cohen N; Mendes O; Kim HT
J Vet Diagn Invest; 2004 May; 16(3):240-3. PubMed ID: 15152842
[TBL] [Abstract][Full Text] [Related]
36. Pleural mesothelioma metastasis of the scalp.
Bicak T; Ozekinci S; İbiloğlu İ
Pol J Pathol; 2023; 74(4):297-301. PubMed ID: 38477094
[TBL] [Abstract][Full Text] [Related]
37. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
Xing D; Banet N; Sharma R; Vang R; Ronnett BM; Illei PB
Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740
[TBL] [Abstract][Full Text] [Related]
38. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
[TBL] [Abstract][Full Text] [Related]
39. [Pseudo-mesotheliomatous adenocarcinoma of the lung].
Aumann K; Günter J; Freudenberg N
Pathologe; 2010 Jul; 31(4):283-9. PubMed ID: 19830430
[TBL] [Abstract][Full Text] [Related]
40. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
Blum W; Schwaller B
Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
